BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10477103)

  • 1. Permeability of iodinated and MR contrast media through two types of hemodialysis membrane.
    Ueda J; Furukawa T; Higashino K; Yamamoto T; Ujita H; Sakaguchi K; Araki Y
    Eur J Radiol; 1999 Jul; 31(1):76-80. PubMed ID: 10477103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Permeability of gadolinium-DTPA through two types of hemodialysis membrane.
    Ueda J; Furukawa T; Yamamoto T; Sakaguchi K; Araki Y
    Invest Radiol; 1998 Oct; 33(10):734-7. PubMed ID: 9788135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Permeability of contrast media through hemodialysis membrane.
    Furukawa T; Ueda J; Higashino K; Takahashi S; Sakaguchi K; Imai T
    Acta Radiol; 1997 Sep; 38(5):918-21. PubMed ID: 9332256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incompatibility of papaverine with various intravascular contrast agents.
    Burbridge BE
    Radiology; 1993 Oct; 189(1):287. PubMed ID: 8267741
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of the surface potential of the hemodialysis membrane and the electrical charge of the gadolinium contrast medium on dialyzability.
    Okada S; Inoue K; Kijima T; Katagiri K; Kumazaki T
    J Nippon Med Sch; 2003 Feb; 70(1):12-5. PubMed ID: 12646970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is a mixture of gadolinium and iodinated contrast material safe during MR arthrography?
    Brown RR; Clarke DW; Daffner RH
    AJR Am J Roentgenol; 2000 Oct; 175(4):1087-90. PubMed ID: 11000170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Technical considerations for injection of a mixture of iodinated contrast material and Artirem for combined CT and MR arthrography].
    Detreille R; Sauer B; Zabel JP; Batch T; Zhu X; Blum A
    J Radiol; 2007 Jun; 88(6):863-9. PubMed ID: 17652979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clearance of gadolinium contrast agent by hemodialysis: in vitro and clinical studies].
    Katagiri K; Okada S; Kumazaki T; Tsuboi N
    Nihon Igaku Hoshasen Gakkai Zasshi; 1998 Nov; 58(13):739-44. PubMed ID: 9866990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MR arthrography: impact of steroids, local anesthetics, and iodinated contrast material on gadolinium signal intensity in phantoms at 1.5 and 3.0 T.
    Ugas MA; Huynh BH; Fox MG; Patrie JT; Gaskin CM
    Radiology; 2014 Aug; 272(2):475-83. PubMed ID: 24661248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gadopentetate dimeglumine and iodinated contrast media. Hemodynamic side effects after bolus injections in pigs.
    Kuhtz-Buschbeck JP; Ehrhardt K; Köhnlein S; Radtke W; Heintzen P
    Invest Radiol; 1997 Feb; 32(2):111-9. PubMed ID: 9039584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal tolerance of gadolinium-DOTA and gadolinium-DTPA in rats.
    Brillet G; Dubois M; Beaufils H; Bourbouze R; Deray G
    Invest Radiol; 1994 Mar; 29(3):352-4. PubMed ID: 8175311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Artificial contrasting during magnetic resonance tomography].
    Sergeev PV; Panov OV; Egorova SV; Bolotova EN; Shimanovskii NL; Akhadov TA; Sviridov NK
    Vestn Rentgenol Radiol; 1997; (1):45-52. PubMed ID: 9133071
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro histamine release induced by magnetic resonance imaging and iodinated contrast media.
    Baxter AB; Lazarus SC; Brasch RC
    Invest Radiol; 1993 Apr; 28(4):308-12. PubMed ID: 7683008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extravascular toxicity of two magnetic resonance contrast agents. Preliminary experience in the rat.
    Cohan RH; Leder RA; Herzberg AJ; Hedlund LW; Wheeler CT; Beam CA; Nadel SN; Dunnick NR
    Invest Radiol; 1991 Mar; 26(3):224-6. PubMed ID: 2055727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton relaxation enhancement associated with iodinated contrast agents in MR imaging of the CNS.
    Jinkins JR; Robinson JW; Sisk L; Fullerton GD; Williams RF
    AJNR Am J Neuroradiol; 1992; 13(1):19-27. PubMed ID: 1595441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gadolinium-enhanced MR imaging of renal masses.
    Rominger MB; Kenney PJ; Morgan DE; Bernreuter WK; Listinsky JJ
    Radiographics; 1992 Nov; 12(6):1097-116; discussion 1117-8. PubMed ID: 1439014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo quantification of the blood-brain barrier injury using magnetic resonance enhancement.
    Hayakawa K; Yamashita K; Mitsumori M; Nakano Y
    Invest Radiol; 1990 Sep; 25 Suppl 1():S80-1. PubMed ID: 2283266
    [No Abstract]   [Full Text] [Related]  

  • 18. MR portography: preliminary comparison with CT portography and conventional MR imaging.
    Dravid VS; Shapiro MJ; Mitchell DG; Outwater EK; Piccoli CW; Feld RI; Wechsler RJ; Rosato FE
    J Magn Reson Imaging; 1994; 4(6):767-71. PubMed ID: 7865935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of pseudocapsule of renal cell carcinoma with MR imaging and CT.
    Yamashita Y; Honda S; Nishiharu T; Urata J; Takahashi M
    AJR Am J Roentgenol; 1996 May; 166(5):1151-5. PubMed ID: 8615260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood-brain barrier injury following intracarotid injection of radiographic contrast media. In vivo quantification using magnetic resonance imaging and Gd-DTPA.
    Hayakawa K; Yamashita K; Mitsumori M; Nakano Y
    Acta Radiol; 1990 Mar; 31(2):203-8. PubMed ID: 2372465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.